Bilal Bin Hafeez is an Assistant Professor at the School of Medicine, University of Texas Rio Grande Valley. He received an MS and a PhD in Toxicology from Hamdard University, Delhi, India, a Postdoctoral degree in Immunopharmacology & Therapeutics from Roswell Park Cancer Institute, and a Postdoctoral degree in Cancer Biology from the University of Wisconsin-Madison. His lab research on pancreatic is funded by the Cancer Prevention and Research Institute of Texas (CPRIT) and the National Institute of Health (NIH)/ National Cancer Institute (NCI).  He is an ad hoc reviewer of many NIH study sections. His research interests mainly focus on (1) identifying new molecular targets that can be used in rational design for the prevention and treatment of solid tumors, mainly prostate, liver and pancreatic cancers, and (2) Developing ribosome biogenesis components as a prognostic biomarkers and their target in cancer therapy.